I thought I would run this through my standard Sol5.6paid prompt on extra high thinking. The reason for that is that I go for high B12 and B9 Obviously this is an issue where it should be possible to attempt a consensus.
chatGPT:
Bottom line
Majumder, Bano and Nayak (2024) is a broad narrative review arguing that one-carbon metabolism connects aging with cancer development. Its novelty lies mainly in assembling these subjects into one framework; it presents no new experimental data and does not establish that altered one-carbon metabolism is a major cause of the age-related rise in cancer.
It is a useful conceptual introduction, but the mechanistic argument is uneven and several biochemical and citation errors mean it should not be treated as an authoritative evidence synthesis.
Summary
One-carbon metabolism transfers single-carbon units through interconnected folate, methionine, serine–glycine and transsulfuration pathways.
Its major outputs include:
- Purines and thymidylate for DNA and RNA synthesis.
- S-adenosylmethionine (SAM) for DNA, RNA, protein and histone methylation.
- NADPH for reductive metabolism.
- Cysteine and glycine for glutathione synthesis.
- Polyamines and other biosynthetic products.
In cancer
The authors argue that rapidly proliferating cancer cells increase their dependence on this network through:
- “Methionine addiction”: many cultured cancer cells cannot proliferate normally when methionine is replaced by homocysteine.
- Increased serine uptake or de novo serine synthesis.
- Increased expression or amplification of PHGDH, SHMT2, MTHFD2, TYMS and DHFR.
- mTOR–ATF4 and NRF2 signalling that promotes serine synthesis, mitochondrial folate metabolism and antioxidant capacity.
- Increased SAM-dependent methylation, nucleotide production and NADPH/glutathione production.
MTHFD2 and SHMT2 are presented as particularly attractive cancer-selective targets because they are frequently elevated in tumours.
In aging
The review associates aging with:
- Altered folate and methionine metabolism.
- Increased homocysteine.
- Changes in SAM availability and DNA/histone methylation.
- Reduced NADPH and glutathione redox capacity.
- Telomere instability and cellular senescence.
- Mitochondrial dysfunction and oxidative damage.
Animal studies of methionine restriction, glycine metabolism and increased transsulfuration are cited as evidence that manipulating this network can affect lifespan.
One particularly interesting example is the 2024 finding that aged muscle stem cells divert SAM toward polyamine production, depleting the SAM available for heterochromatin maintenance. SAM supplementation or inhibition of polyamine synthesis partly restored stem-cell function.
Proposed aging–cancer connection
The implied model is:
Age-related metabolic and redox disruption → epigenetic instability and DNA damage → senescence or preneoplastic lesions → selection of cells that reactivate one-carbon metabolism → tumour proliferation.
Senescence and apoptosis initially suppress cancer, but persistent senescent cells and their SASP may subsequently create a pro-inflammatory, tumour-promoting environment.
What is genuinely novel?
The paper’s novelty is low experimentally but moderate conceptually.
The most useful synthesis is the juxtaposition of two apparently opposing states:
| Aging tissues |
Established cancer cells |
| Often impaired or imbalanced one-carbon metabolism |
Frequently increased one-carbon flux |
| SAM depletion and epigenetic drift |
High SAM demand and altered methylation |
| Reduced redox resilience |
Increased NADPH and glutathione production |
| Senescence and reduced proliferation |
Methionine dependence and rapid proliferation |
This suggests a potentially important stage-dependent model: one-carbon insufficiency or imbalance might contribute to tumour initiation, whereas increased one-carbon flux supports tumour maintenance and progression.
However, the authors do not develop this into a sufficiently precise or testable temporal model. Most of the individual components—methionine addiction, serine metabolism, MTHFD2, SAM-dependent chromatin regulation and methionine-restriction longevity—were already well established.
Strengths
- It treats one-carbon metabolism as more than nucleotide synthesis, incorporating methylation, redox control and polyamine metabolism.
- It highlights mitochondrial enzymes such as MTHFD2 and SHMT2.
- It recognises that folate and other nutrients can be protective in one context but potentially tumour-supporting in another.
- It brings together cancer metabolism, aging, senescence and chromatin regulation in an accessible way.
- The SAM-depletion example in aged muscle stem cells provides a credible mechanistic link between metabolite allocation and chromatin deterioration.
Major criticisms
1. It is not a systematic review
No search strategy, databases, inclusion criteria, study-quality assessment or evidence grading are provided. The paper therefore cannot establish the balance of the literature or support the word “pivotal” quantitatively.
2. The central causal bridge is not demonstrated
The review separately establishes that:
- one-carbon metabolism changes with age; and
- tumours depend on one-carbon metabolism.
That does not prove that age-related one-carbon disruption causes neoplastic transformation. The paper does not compare this mechanism with mutation accumulation, clonal selection, immune aging, stromal changes or declining tumour surveillance.
3. It does not resolve the direction-of-effect paradox
If reduced folate/SAM availability contributes to aging and genomic instability, but tumours require increased one-carbon flux, then intervention depends critically on disease stage.
The review does not specify when restoring one-carbon metabolism would protect normal tissue and when it might feed an occult tumour. This is the principal translational problem.
4. Concentration and expression are repeatedly treated as flux
Serum folate, plasma B12, homocysteine, enzyme expression and gene amplification do not directly measure pathway flux. Compartment-specific isotope tracing is needed to establish whether carbon is flowing into nucleotides, SAM, formate, NADPH or glutathione.
This matters because cytosolic, mitochondrial and nuclear one-carbon metabolism can behave differently.
5. Excessive extrapolation
Evidence from cultured cancer cells, worms, flies, yeast and severe methionine restriction in rodents is frequently discussed together without adequate separation. Methionine restriction of around 80% in rodents is not automatically a practicable or safe human cancer-prevention intervention.
Similarly, methionine addiction in cell culture does not establish that normal human tissues and tumours have a sufficiently large therapeutic difference in vivo.
6. The senescence discussion is weakly connected to one-carbon metabolism
Section 6.2 says little about how one-carbon metabolism actually causes or regulates senescence. Later sections become a general review of p53, p16, apoptosis and SASP, rather than maintaining a direct metabolic argument.
The claim that apoptosis and senescence have essentially the same outcome is misleading: apoptosis removes the cell, whereas senescence generally leaves a metabolically active cell capable of producing SASP.
Specific errors and citation problems
Several spot checks raised significant concerns:
- The paper calls sarcosine “dimethylglycine.” Sarcosine is monomethylglycine; dimethylglycine is a different metabolite.
- It states that “cystine” is produced through one-carbon metabolism when the intended metabolite appears to be cysteine through transsulfuration.
- Reference 119 is cited for lifespan extension by intestinal or muscle
cbs-1 overexpression in C. elegans, but the listed paper concerns prostaglandin signalling from germline stem cells.
- References 168 and 169 are cited in support of methionine restriction reducing metabolic disease markers, but the listed papers concern vitamin D, PPARÎł polymorphism and diabetes.
- Reference 124 is used to support targeting senescent cells in progeroid models, but it is a review of growth-hormone signalling.
- A multicomponent dietary-supplement study is used to imply a lifespan benefit from folate, although the effect cannot be attributed specifically to folate.
- Elevated circulating B12 is presented in a way that risks implying causation. In cancer it can instead be a consequence or marker of occult malignancy, inflammation, liver dysfunction or altered binding proteins.
- The paper describes adult senescence as irreversible while citing a 2024 paper specifically emphasising that the reversible/irreversible distinction is more complicated.
These may partly reflect poor editing or citation-number errors, but they materially reduce confidence in the review.
Relevance to your citrate–acetyl-CoA hypothesis
The paper supports the broader principle that metabolite supply governs chromatin state. The SAM/polyamine competition in aged muscle stem cells is particularly analogous to your proposal that inadequate nuclear acetyl-CoA could limit histone acetylation during differentiation.
However, it provides little direct evidence for your specific axis:
mitochondrial citrate export → ACLY → nuclear acetyl-CoA → histone acetylation → transcription and splicing.
Acetyl-CoA and histone acetylation receive only passing treatment. Citrate export, SLC25A1, ACLY, local nuclear acetyl-CoA production, transcription of long genes and splicing fidelity are not analysed. The paper is therefore complementary to your hypothesis, but not direct support for it.
Overall: a useful source of hypotheses and references, especially around SAM allocation and mitochondrial folate enzymes, but its causal conclusions and individual citations need independent verification.
